Abstract
Background
In breast tissue, pre-malignant lesions are classified as BIRADS 3. The treatment of this heterogeneous group varies with expertise and tools available.
Materials and methods
With the example of two case reports, the literature is reviewed on current treatment options for BIRADS 3 breast lesions.
Results
About 7% of all B-type breast biopsies fall into the B3 category. Approximately 35% of these B3 lesions are due to FEA, 20% to PLs and another 20% to ADH. Due to improvement in diagnostics, the incidence is increasing, while their value as a predictive factor for malignancy has steadily been fallen.
Conclusion
Depending on the histology of the needle biopsy, a complete resection with vacuum-assisted biopsy may be a treatment alternative to open biopsy.
This is a preview of subscription content, log in via an institution to check access.
References
Rageth CJ, O’Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H et al (2016) First international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 159:203–213
Lakhani S, Ellis I, Schnitt S, Tan P, van de Vijve M (2012) WHO classification of tumours of the breast, 4th edn. In: Lakhani S, Ellis I, Schnitt S, Tan P, van de Vijve M (eds) International Agency for Research on C, Lyon
Noske A, Pahl S, Fallenberg E, Richter-Ehrenstein C, Buckendahl A-C, Weichert W et al (2010) Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology. Hum Pathol 41:522–527
Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD et al (2004) Best practice no 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 57:897–902
Rakha EA, Ho BC, Naik V, Sen S, Hamilton LJ, Hodi Z et al (2011) Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia. Histopathology. 58:626–632
El-Sayed ME, Rakha EA, Reed J, Lee AH, Evans AJ, Ellis IO (2008) Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. Eur J Cancer 44:2580–2586
Tavassoli F, Norris H (1990) A comparison of the results of long-term follow-up for atypical intraductal hyperplasia and intraductal hyperplasia of the breast. Cancer 65:518–529
Renshaw AA, Gould EW (2016) Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. Pathology 48(1):25–29
Arbeitsgemeinschaft Gynäkologische Onkologie. Diagnosis and treatment of patients with primary and metastatic breast cancer lesions of uncertain malignant potential (B3) (2018) https://www.ago-online.de/en/guidelines-mamma/march-2018/. Accessed 20 Aug 2018
Kuerer HM (2015) Ductal carcinoma in situ: treatment or active surveillance? Expert Rev Anticancer Ther 15:777–785
Calhoun BC, Collie AMB, Lott-Limbach AA, Udoji EN, Sieck LR, Booth CN et al (2016) Lobular neoplasia diagnosed on breast core biopsy: frequency of carcinoma on excision and implications for management. Ann Diagn Pathol 25:20–25
Bianchi S, Bendinelli B, Saladino V, Vezzosi V, Brancato B, Nori J et al (2015) Non-malignant breast papillary lesions—b3 diagnosed on ultrasound-guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature. Pathol Oncol Res 21:535–546
Heywang-Köbrunner SH, Nährig J, Hacker A, Sedlacek S, Höfler H (2010) B3 lesions: radiological assessment and multi-disciplinary aspects. Breast Care (Basel) 5:209–217
Saladin C, Haueisen H, Kampmann G, Oehlschlegel C, Seifert B, Rageth L et al (2016) Lesions with unclear malignant potential (B3) after minimally invasive breast biopsy: evaluation of vacuum biopsies performed in Switzerland and recommended further management. Acta Radiol 57:815–821
Liberman L, Tornos C, Huzjan R, Bartella L, Morris EA, Dershaw DD (2006) Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? Am J Roentgenol 186:1328–1334
Author information
Authors and Affiliations
Contributions
IB: methodology, equal writing—review and editing, and supporting. AdG: conceptualization, equal resources, equal writing—original draft, and supporting. AdW: data curation, supporting writing—review and editing, and supporting. AN: resources, equal writing—original draft, and supporting. JdW: conceptualization, equal project administration, supporting writing—review and editing, equal conceptualization, equal project administration, supporting writing—review and editing, and equal. JW: resources, supporting supervision, equal writing—review and editing, and supporting. FE: conceptualization, lead formal analysis, equal methodology, equal project administration, lead writing—original draft, and lead.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bekes, I., deGregorio, A., deWaal, A. et al. Review on current treatment options for lesions of uncertain malignant potential (B3 lesions) of the breast: do B3 papillary lesions need to be removed in any case by open surgery?. Arch Gynecol Obstet 300, 481–484 (2019). https://doi.org/10.1007/s00404-018-4985-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-018-4985-0